Company / Shares Outstanding
Verrica Pharmaceuticals Inc. Shares Outstanding History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
9.2M
FY2025
5-year range
9.2M / 42.4M
FY2021-FY2025
Trend
-78.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 41094053.00 to 9177999.00 over the past 2 years.
Based on SEC 10-K filings.
9177999.00 in FY2025 with a 3-year CAGR of -30.7%.
Improved from 41094053.00 to 9177999.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -30.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding decreased 78.4% year-over-year.
- Peak shares outstanding was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 9.2M | -78.4% |
| FY2024 | 42.4M | +3.2% |
| FY2023 | 41.1M | +49.3% |
| FY2022 | 27.5M | +8.2% |
| FY2021 | 25.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026